The metabolic syndrome in women

J. Gabriel Schneider, Christine Tompkins, Roger S Blumenthal, Samia Mora

Research output: Contribution to journalArticle

Abstract

The metabolic syndrome, an increasingly prevalent disorder, is known to significantly enhance the risk of developing cardiovascular disease and diabetes. The syndrome is defined by a constellation of cardiac risk factors that include obesity, atherogenic dyslipidemia, hypertension, and insulin resistance. There are several unique features of the metabolic syndrome in women. An insulin-resistant state associated with both polycystic ovarian syndrome and increased abdominal fat may contribute to the development of the metabolic syndrome and increase cardiovascular risk when present. Menopause heralds a decline in circulating estrogen levels, which may increase cardiovascular risk through effects on adiposity, lipid metabolism, and prothrombotic state. The key elements involved in managing the metabolic syndrome are dietary and lifestyle modification. Appropriate treatment may also include managing individual cardiac risk factors with the use of antihypertensive and lipid-modifying agents among others.

Original languageEnglish (US)
Pages (from-to)286-291
Number of pages6
JournalCardiology in Review
Volume14
Issue number6
DOIs
StatePublished - Nov 2006

Fingerprint

Metabolic Syndrome X
Diet Therapy
Abdominal Fat
Polycystic Ovary Syndrome
Adiposity
Dyslipidemias
Menopause
Lipid Metabolism
Antihypertensive Agents
Insulin Resistance
Life Style
Estrogens
Cardiovascular Diseases
Obesity
Insulin
Hypertension
Lipids
Therapeutics

Keywords

  • Cardiovascular risk in women
  • Diabetes in women
  • Lipid disorders
  • Metabolic syndrome
  • Polycystic ovarian syndrome
  • Syndrome X

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The metabolic syndrome in women. / Schneider, J. Gabriel; Tompkins, Christine; Blumenthal, Roger S; Mora, Samia.

In: Cardiology in Review, Vol. 14, No. 6, 11.2006, p. 286-291.

Research output: Contribution to journalArticle

Schneider, JG, Tompkins, C, Blumenthal, RS & Mora, S 2006, 'The metabolic syndrome in women', Cardiology in Review, vol. 14, no. 6, pp. 286-291. https://doi.org/10.1097/01.crd.0000233757.15181.67
Schneider, J. Gabriel ; Tompkins, Christine ; Blumenthal, Roger S ; Mora, Samia. / The metabolic syndrome in women. In: Cardiology in Review. 2006 ; Vol. 14, No. 6. pp. 286-291.
@article{985aa26d46bc466cb0675b38833fc2be,
title = "The metabolic syndrome in women",
abstract = "The metabolic syndrome, an increasingly prevalent disorder, is known to significantly enhance the risk of developing cardiovascular disease and diabetes. The syndrome is defined by a constellation of cardiac risk factors that include obesity, atherogenic dyslipidemia, hypertension, and insulin resistance. There are several unique features of the metabolic syndrome in women. An insulin-resistant state associated with both polycystic ovarian syndrome and increased abdominal fat may contribute to the development of the metabolic syndrome and increase cardiovascular risk when present. Menopause heralds a decline in circulating estrogen levels, which may increase cardiovascular risk through effects on adiposity, lipid metabolism, and prothrombotic state. The key elements involved in managing the metabolic syndrome are dietary and lifestyle modification. Appropriate treatment may also include managing individual cardiac risk factors with the use of antihypertensive and lipid-modifying agents among others.",
keywords = "Cardiovascular risk in women, Diabetes in women, Lipid disorders, Metabolic syndrome, Polycystic ovarian syndrome, Syndrome X",
author = "Schneider, {J. Gabriel} and Christine Tompkins and Blumenthal, {Roger S} and Samia Mora",
year = "2006",
month = "11",
doi = "10.1097/01.crd.0000233757.15181.67",
language = "English (US)",
volume = "14",
pages = "286--291",
journal = "Cardiology in Review",
issn = "1061-5377",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - The metabolic syndrome in women

AU - Schneider, J. Gabriel

AU - Tompkins, Christine

AU - Blumenthal, Roger S

AU - Mora, Samia

PY - 2006/11

Y1 - 2006/11

N2 - The metabolic syndrome, an increasingly prevalent disorder, is known to significantly enhance the risk of developing cardiovascular disease and diabetes. The syndrome is defined by a constellation of cardiac risk factors that include obesity, atherogenic dyslipidemia, hypertension, and insulin resistance. There are several unique features of the metabolic syndrome in women. An insulin-resistant state associated with both polycystic ovarian syndrome and increased abdominal fat may contribute to the development of the metabolic syndrome and increase cardiovascular risk when present. Menopause heralds a decline in circulating estrogen levels, which may increase cardiovascular risk through effects on adiposity, lipid metabolism, and prothrombotic state. The key elements involved in managing the metabolic syndrome are dietary and lifestyle modification. Appropriate treatment may also include managing individual cardiac risk factors with the use of antihypertensive and lipid-modifying agents among others.

AB - The metabolic syndrome, an increasingly prevalent disorder, is known to significantly enhance the risk of developing cardiovascular disease and diabetes. The syndrome is defined by a constellation of cardiac risk factors that include obesity, atherogenic dyslipidemia, hypertension, and insulin resistance. There are several unique features of the metabolic syndrome in women. An insulin-resistant state associated with both polycystic ovarian syndrome and increased abdominal fat may contribute to the development of the metabolic syndrome and increase cardiovascular risk when present. Menopause heralds a decline in circulating estrogen levels, which may increase cardiovascular risk through effects on adiposity, lipid metabolism, and prothrombotic state. The key elements involved in managing the metabolic syndrome are dietary and lifestyle modification. Appropriate treatment may also include managing individual cardiac risk factors with the use of antihypertensive and lipid-modifying agents among others.

KW - Cardiovascular risk in women

KW - Diabetes in women

KW - Lipid disorders

KW - Metabolic syndrome

KW - Polycystic ovarian syndrome

KW - Syndrome X

UR - http://www.scopus.com/inward/record.url?scp=33750371468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750371468&partnerID=8YFLogxK

U2 - 10.1097/01.crd.0000233757.15181.67

DO - 10.1097/01.crd.0000233757.15181.67

M3 - Article

VL - 14

SP - 286

EP - 291

JO - Cardiology in Review

JF - Cardiology in Review

SN - 1061-5377

IS - 6

ER -